Calculation of Exchange Ratio. The number of BCI Shares to be issued to each of the XXXX Shareholders for their respective XXXX Shares shall be calculated in accordance with the formula in Section 2.2, using an exchange ratio of 0.7258 (the "Exchange Ratio"). The Exchange Ratio was derived by dividing the total number of BCI Shares to be issued (14,516,000) by the total number of XXXX Shares to be delivered to BCI (20,000,000). In so doing, BCI shall round the result to the nearest whole number (subject to other reasonable adjustments needed to maintain the total number of BCI Shares to be issued is 14,516,000). No fractional shares of BCI common stock shall be issued in connection with the Acquisition.
Appears in 12 contracts
Samples: Purchase and Sale Agreement With Proxy (Enhance Biotech Inc), Purchase and Sale Agreement With Proxy (Enhance Biotech Inc), Purchase and Sale Agreement With Proxy (Enhance Biotech Inc)
Calculation of Exchange Ratio. The number of BCI Shares to be issued to each of the XXXX Shareholders for their respective XXXX Shares shall be calculated in accordance with the formula in Section 2.2, using an exchange 102 ratio of 0.7258 (the "Exchange Ratio"). The Exchange Ratio was derived by dividing the total number of BCI Shares to be issued (14,516,000) by the total number of XXXX Shares to be delivered to BCI (20,000,000). In so doing, BCI shall round the result to the nearest whole number (subject to other reasonable adjustments needed to maintain the total number of BCI Shares to be issued is 14,516,000). No fractional shares of BCI common stock shall be issued in connection with the Acquisition.
Appears in 1 contract
Samples: Purchase and Sale Agreement With Proxy (Enhance Biotech Inc)
Calculation of Exchange Ratio. The number of BCI Shares to be issued to each of the XXXX Shareholders for their respective XXXX Shares shall 108 be calculated in accordance with the formula in Section 2.2, using an exchange ratio of 0.7258 (the "Exchange Ratio"). The Exchange Ratio was derived by dividing the total number of BCI Shares to be issued (14,516,000) by the total number of XXXX Shares to be delivered to BCI (20,000,000). In so doing, BCI shall round the result to the nearest whole number (subject to other reasonable adjustments needed to maintain the total number of BCI Shares to be issued is 14,516,000). No fractional shares of BCI common stock shall be issued in connection with the Acquisition.
Appears in 1 contract
Samples: Purchase and Sale Agreement With Proxy (Enhance Biotech Inc)